What is NDC 83708-111?

83708-111 is the product NDC for Bondlido (lidocaine), Lidocaine 200 mg/1 system, listed with the FDA by MEDRx USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

MEDRx USA, Inc., NDC labeler code 83708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bondlido?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bondlido NDC 83708-111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83708-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83708-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83708-111-01	83708011101	1 CARTON in 1 PATCH (83708-111-01) / 28 SYSTEM in 1 CARTON (83708-111-28)Marketed from Oct 8, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bondlido
Generic name (nonproprietary): lidocaine
Active ingredients: Lidocaine — 200 mg/1
Dosage form: System
Route: Topical
Labeler: MEDRx USA, Inc.NDC labeler code 83708
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 215029
Marketing start: Oct 8, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 83708-111_bf5114c2-b1b2-4f39-b76d-8931cc6a8f72SPL ID bf5114c2-b1b2-4f39-b76d-8931cc6a8f72SPL set ID 17e69028-d2c2-4080-8090-cb0cab570196UNII 98PI200987
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483708011101 followed by a unit qualifier and the quantity

Package 83708-0111-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 6, 2025.

Indications (excerpt from the label)

BONDLIDO (lidocaine topical system 10%) is indicated in adults for relief of pain associated with post-herpetic neuralgia (PHN). BONDLIDO contains lidocaine, an amide local anesthetic, and is indicated in adults for relief of pain associated with post-herpetic neuralgia (PHN) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83708-111

What is NDC 83708-111?: 83708-111 is the product NDC for Bondlido (lidocaine), Lidocaine 200 mg/1 system, listed with the FDA by MEDRx USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bondlido (Lidocaine).
What is the active ingredient?: Lidocaine.
Who is the labeler?: MEDRx USA, Inc., NDC labeler code 83708. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bondlido?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Bondlido (Lidocaine) NDC 83708-111